Part 2: The Coadministration of COVID-19 and Flu VaccinesDecember 1st 2021
Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss the benefits of the coadministration of COVID-19 and flu vaccines in part 2 of this interview.
Vaccinology: New Vaccine Technology for Autoimmune, Cancers, Infectious DiseasesNovember 12th 2021
Vaccine technologies in development may facilitate a rapid and effective response to new threats and likely will target not only infectious diseases but also allergies, autoimmune conditions, and cancers.
FDA Delays Adolescent COVID-19 Vaccine EUA Announcement for Moderna VaccineNovember 3rd 2021
The FDA has notified Moderna that it will need additional time to complete its evaluation of Moderna’s EUA request for the use of the company’s COVID-19 vaccine at the 100-µg dose level in adolescents between 12 and 17 years.